Malignant Myeloma in a Patient After Treatment for Osteoporosis with Teriparatide; a Rare Coincidence

@inproceedings{Forslund2008MalignantMI,
  title={Malignant Myeloma in a Patient After Treatment for Osteoporosis with Teriparatide; a Rare Coincidence},
  author={Terje Forslund and Anna-Mari Koski and Arvo Koistinen and Anu Siki{\"o}},
  booktitle={Clinical medicine. Case reports},
  year={2008}
}
A breakthrough in understanding of mechanisms of bone structure regulation has brought about the introduction of the new synthetic recombinant human parathyroid hormone 1-34 (PTH1-34; Teriparatide) in the treatment of osteoporosis. These mechanisms, involving the RANKL, RANK, and osteoprotegerin system, are also known to be involved in malignant myeloma (MM) and tumor and bone metastasis development. We report a case in which MM was found after treatment of osteoporosis with teriparatide. We… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Biology of neoplasia. Biology of osteoclast activation in cancer

  • G. D. Rodman
  • J. Clin. Oncol.,
  • 2001
Highly Influential
12 Excerpts

Similar Papers

Loading similar papers…